Business Wire
20 Oct 2026, 20:35 UTC · 3h ago
Impact · against what's priced in
Darling Ingredients expands its addressable market by entering the cognitive health supplement space via a new collagen peptide. This represents a diversification of the Rousselot brand's product pipeline beyond traditional health applications.
No priced-in read yet
What the story claims
1 claim · scored −1 bearish … +1 bullish · 1 new · 0 priced in
Darling Ingredients and its brand Rousselot introduced Nextida NxCogni, a collagen peptide designed for cognitive resilience and clarity.
Newpress release dated 2026-10-20
So whatEntry into the cognitive health supplement market expands the addressable TAM for the Rousselot segment starting in FY2027.
More positive than 57% of claims this week
Which stocks this story touches
Continue reading
5 related stories
The launch of Nextida NxCogni opens a new revenue stream in cognitive health and resilience, expanding the total addressable market for the Rousselot segment.
Read from the article alone
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More positive than 91% of ticker scores this week
The company is launching a first-of-its-kind targeted collagen peptide ingredient to expand its health brand offerings.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
The Motley Fool
1h ago
—
DAR hasn't traded since this ran. Last close $59.22 (Oct 20); the reaction starts at the next open.
DAR chart →
